Blood Irradiator Market was valued at 346.8 Million USD in 2020 and will grow at CAGR Value by .57% by 2020-2027 Says Coherent Market Insights

Blood Irradiator Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Blood Irradiator Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.

Blood Irradiator Market Analysis

Blood and blood components are irradiated to limit the development of T cells, which can block the immune response and lead to graft-versus-host disease (GVHD). Blood irradiators are utilised in a variety of medical and research applications, including transfusion preparation and cancer research. Transfusion recipients at risk for GVHD, such as foetuses getting intrauterine transfusions, patients undergoing hematopoietic transplantation, and those receiving platelets, must be irradiated. Blood irradiators are used to irradiate blood, which is necessary for operations, cancer treatment, chronic illnesses, and traumatic injuries.

Get Flat USD 2000 OFF

Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/1972

Reasons to Purchase this Report

• Current and future of global Lab-on-a-chip Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period.
• The latest developments, market shares, and strategies that are employed by the major market players.

Blood Irradiator Market Drivers

Transfusion-associated graft-versus-host disease is a rare but significant consequence of blood transfusion caused by white blood cells in the transfused blood. Irradiated blood is used to prevent this complication. Transfusion-associated graft-versus-host disease (TA-GVHD) occurs when donor lymphocytes from transfused blood engraft in the recipient, causing diseases such as hepatitis, diarrhoea, and pancytopenia with clinical features of fever and skin rash, and is fatal in more than 90% of cases, according to the Royal Children’s Hospital Melbourne.

Furthermore, government funding for the development of innovative irradiators to ensure safe blood transfusions is propelling the industry forward. For example, in 2014, Stellarray, Inc., developer of novel x-ray sources, was awarded the US$ 1.1 Mn grant by the Department of Energy to develop and commercialize new generation irradiators for ensuring the safety of blood transfusions by replacing cesium, 137 which is identified as a national security hazard.

Furthermore, the AABB collaborates with the Food and Drug Administration (FDA) to provide adequate irradiation guidance and regulations for blood products, thereby benefitting the blood irradiators market by ensuring security and compliance to limit the use of radioactive irradiators.

However, a lack of public understanding about the applications and benefits of irradiators in healthcare institutions, as well as the expensive cost of irradiators, are limiting market growth. For example, according to the survey by College of American Pathologists, 2017, the cost of X-ray irradiators is around US$ 250,000 to US$ 300,000, with annual service contract accounting for US$ 15,000 to US$ 20,000.

Blood Irradiator Market – Regional Insights

The global blood irradiator market is divided into five regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Because of the introduction and implementation of new technologies, North America now has a prominent position in the global blood irradiators market. For example, in September 2017, Typenex Medical, launched Rad-Control, a new irradiation indicator tag technology in the blood banks and blood centers in the U.S. and Canada. Rad-control ensures that blood component has received irradiation, thereby preventing life threatening transfusion-associated Graft-vs.-Host Disease (TA-GvHD).

Furthermore, increasing use of X-ray irradiator is likely to propel the blood irradiator market forward. The National Nuclear Security Administration (DOE/NNSA) of the US Department of Energy collaborated with the New York City Department of Health and Mental Hygiene (DOHMH) and the Nuclear Threat Initiative (NTI) in 2017 to replace radioactive irradiators with safer X-ray replacements.

Additionally, an increase in the number of people requiring blood transfusions in the region due to various disorders is a major driver driving market expansion. Sickle cell disease affects 90,000 to 100,000 adults in the United States, and about 1,000 babies are born with the disease each year, according to the American National Red Cross. Sickle cell individuals require blood transfusions for the majority of their life. In addition, the American Cancer Society estimates that 1.7 million people will be diagnosed with cancer in 2017, with patients requiring blood as part of their chemotherapy treatment.

In addition, the increased use of blood irradiators in medical settings to prevent and control the transmission of transfusion-associated graft-versus-host disease (TA-GVHD) is likely to drive market growth in North America. In 2013, roughly 500 blood irradiators irradiated around 2 million blood units, according to the Department of Health and Human Services.

Request For Sample Copy Here

Blood Irradiator Market – Competitive Landscape

To boost blood irradiators in the worldwide industry, key companies in the global blood irradiator market are focusing on strategic mergers and acquisitions. For example, Charter Medical and RadTag Technologies cooperated to distribute RadTag blood irradiator indicators in the United States.

Rad Source Technologies, Sukosol Group, Typenex Medical, Gamma-Service Medical GmbH, Cegelec NDT-PES, and Best Theratronics, Ltd. are some of the major participants in the worldwide blood irradiator market.

Blood Irradiator Market – Market Taxonomy

On the basis of product type, the global blood irradiator market is segmented into:

• X-ray Irradiators
• Gamma-ray Irradiators

On the basis of end user, the global blood irradiator market is segmented into:

• Hospitals
• Research Institutions
• Blood Banks

On the basis of region, the global blood irradiator market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837